Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behcet's syndrome

1979 ◽  
Vol 115 (11) ◽  
pp. 1303-1306 ◽  
Author(s):  
P. G. Hazen
1989 ◽  
Vol 21 (2) ◽  
pp. 327-330 ◽  
Author(s):  
Seung Hun Lee ◽  
Kee Yang Chung ◽  
Won Soo Lee ◽  
Sungnack Lee

2021 ◽  
Vol 8 ◽  
Author(s):  
Ina Kötter ◽  
Fabian Lötscher

Behçet‘s Syndrome (BS) is a variable vessel vasculitis according to the Chapel Hill Consensus Nomenclature (1) and may thus affect any organ, including major and minor arterial and venous vessels to a varying degree and with varying frequency. Although the main features of BS are recurrent oral and genital aphthous ulcers, cutaneous lesions, ocular inflammation and arthritis—major vessel and life—or organ threatening involvement of internal organs and the central and peripheral nervous system occur. In general, BS in Europe appears to form six phenotypes of clinical manifestations (2), which are (1) mucocutaneous only, (2) predominant arthritis/articular involvement, (3) vascular phenotype, (4) ocular manifestations, which are most likely associated with CNS manifestations and HLA-B51, (5) dominant parenchymal CNS manifestations (being associated with the ocular ones), and (6) gastrointestinal involvement. Mucocutaneous manifestations are present in almost all patients/all phenotypes. In the following review, we summarize the current knowledge concerning vascular, neurologic, gastrointestinal and musculoskeletal manifestations of the disease.


1970 ◽  
Vol 102 (1) ◽  
pp. 116-117 ◽  
Author(s):  
J. L. Fromer

1987 ◽  
Vol 28 (4) ◽  
pp. 291 ◽  
Author(s):  
Moon Soo Yoon ◽  
Seung Hun Lee ◽  
Dong Sik Bang ◽  
Sungnack Lee

2021 ◽  
Vol 77 (18) ◽  
pp. 2791
Author(s):  
Neiberg De Alcantara Lima ◽  
Henrique Carvalho Lima Farias ◽  
Ane Karoline Medina Neri ◽  
Danielli Lino ◽  
Isabela Thomáz Takakura Guedes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document